Left to right: Rafael Aguirre-Sacasa, General Counsel and Koren Temple-Perry, Senior Director of Marketing Communications The California Institute for Regenerative Medicine (CIRM) continues to build its world class team to deliver the full potential of regenerative medicine to the people of California and around the world. CIRM is pleased to welcome two new members to its … Continue reading CIRM welcomes two additions to its leadership team
CIRM News
Apply Now! Discovery Stage Funding + Webinar on April 7
The California Institute for Regenerative Medicine (CIRM) is pleased to announce the opening of our next round of Quest Awards (DISC2) for discovery stage research. The purpose of the Quest Awards is to promote discovery of promising new stem cell-based and/or gene therapy technologies that could be translated to enable broad use and ultimately, improve patient care. The expected … Continue reading Apply Now! Discovery Stage Funding + Webinar on April 7
CIRM welcomes new Chair, bids farewell to Art Torres and Jonathan Thomas
Dr. Vito Imbasciani was sworn in as the new Chair of the Board of the California Institute for Regenerative Medicine (CIRM) at its March meeting. Imbasciani (pictured above at left) was elected to the six-year term at CIRM’s January Board meeting. He will replace outgoing chair Jonathan Thomas, who has served in the position since 2011. “My experience … Continue reading CIRM welcomes new Chair, bids farewell to Art Torres and Jonathan Thomas
CIRM board member Ysabel Duron appointed to National Cancer Advisory Board by President Biden
Ysabel Duron is an award-winning journalist, patient advocate, cancer survivor and board member of the California Institute for Regenerative Medicine (CIRM). Her list of achievements continues to grow, as President Biden has appointed Duron to National Cancer Advisory Board (NCAB), which plays an important role in setting the course for the national cancer research program. … Continue reading CIRM board member Ysabel Duron appointed to National Cancer Advisory Board by President Biden
California agency invests $4 million in stem cell treatment for Parkinson’s Disease
The California Institute for Regenerative Medicine (CIRM) is investing $4 million in a late-stage preclinical project by Ryne Bio aiming to improve treatment for Idiopathic Parkinson's disease (PD). PD is characterized by a loss of dopamine producing neurons that result in motor symptoms, such as dyskinesias (involuntary, erratic, writhing movements of the face, arms, legs … Continue reading California agency invests $4 million in stem cell treatment for Parkinson’s Disease
Dr. Vito Imbasciani elected as Chair of California stem cell agency
Dr. Vito Imbasciani will be the new Chair of the California Institute for Regenerative Medicine (CIRM), the state agency created by voters in 2004 and funded again in 2020 to invest in stem cell and regenerative medicine research and treatments. At January’s Board meeting, the agency’s 35-member Governing Board elected Imbasciani to the six-year term, … Continue reading Dr. Vito Imbasciani elected as Chair of California stem cell agency
Funding development of a vaccine for acute myelogenous leukemia (AML)
Dr. Karin Gaensler. Photo credit: Steve Babuljak/UCSF Adult acute myelogenous leukemia—also known as acute myeloid leukemia (AML)—is a blood cancer in which the bone marrow makes a large number of abnormal blood cells. About 20,000 new cases of AML are diagnosed each year in the US with a 5-year survival rate of around 29%. In … Continue reading Funding development of a vaccine for acute myelogenous leukemia (AML)
CIRM funds clinical trial to make cancer therapy safer, less toxic
Blood stem cell transplantation following high dose chemotherapy is standard of care and potentially curative for aggressive forms of lymphoma. However, this treatment regimen is limited by severe toxicity and life-threatening complications due to delayed recovery of the blood system and vascular related damage of multiple organs. Today the governing Board of the California Institute … Continue reading CIRM funds clinical trial to make cancer therapy safer, less toxic
In Memory of Kevin McCormack
CIRM lost its voice this weekend. Sunday evening, our beloved Director of Patient Advocacy and frequent face and voice of the Institute, Kevin McCormack, passed away unexpectedly, leaving an unfillable void in our hearts. As our chief chronicler of CIRM milestones and celebrator of patients, Kevin brought his unique brand of grace, style and humor … Continue reading In Memory of Kevin McCormack
Three women with ties to CIRM featured in 2022 Women in Biopharma list
Endpoints News released its 2022 Women in Biopharma list, which recognizes 20 of the top women leading biopharma research and development (R&D). This year, the publication received more than 500 entries and selected 20 women “who have blazed trails and are still promising to reshape biopharma R&D for years to come.” There are many amazing … Continue reading Three women with ties to CIRM featured in 2022 Women in Biopharma list
The Stem Cellar 